QuickView for proton-transporting two-sector ATPase complex, catalytic domain (biogroup)

1. GSK cancer cell line transcript profiling
2. Human-hamster radiation hybrid panel (G3) expression mapping
3. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
4. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
5. L1000 CMAP - Colorectal cancer HT29.311 cells with CRISPR-targeted gene knockouts

There were no matches for proton-transporting two-sector ATPase complex, catalytic domain

There were no clinical trials for proton-transporting two-sector ATPase complex, catalytic domain